151 related articles for article (PubMed ID: 30875211)
21. Decreased Gluconeogenesis in the Absence of Cystathionine Gamma-Lyase and the Underlying Mechanisms.
Untereiner AA; Wang R; Ju Y; Wu L
Antioxid Redox Signal; 2016 Jan; 24(3):129-40. PubMed ID: 26401978
[TBL] [Abstract][Full Text] [Related]
22. HMGA1 is a novel transcriptional regulator of the FoxO1 gene.
Arcidiacono B; Chiefari E; Messineo S; Bilotta FL; Pastore I; Corigliano DM; Foti DP; Brunetti A
Endocrine; 2018 Apr; 60(1):56-64. PubMed ID: 29052178
[TBL] [Abstract][Full Text] [Related]
23. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.
Chen Z; Sheng L; Shen H; Zhao Y; Wang S; Brink R; Rui L
Diabetes; 2012 Mar; 61(3):566-73. PubMed ID: 22315325
[TBL] [Abstract][Full Text] [Related]
24. Green tea epigallocatechin gallate inhibits insulin stimulation of adipocyte glucose uptake via the 67-kilodalton laminin receptor and AMP-activated protein kinase pathways.
Hsieh CF; Tsuei YW; Liu CW; Kao CC; Shih LJ; Ho LT; Wu LY; Wu CP; Tsai PH; Chang HH; Ku HC; Kao YH
Planta Med; 2010 Oct; 76(15):1694-8. PubMed ID: 20455202
[TBL] [Abstract][Full Text] [Related]
25. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
[TBL] [Abstract][Full Text] [Related]
26. TGF-β1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis.
Yadav H; Devalaraja S; Chung ST; Rane SG
J Biol Chem; 2017 Feb; 292(8):3420-3432. PubMed ID: 28069811
[TBL] [Abstract][Full Text] [Related]
27. CD38-mediated Ca(2+) signaling contributes to glucagon-induced hepatic gluconeogenesis.
Rah SY; Kim UH
Sci Rep; 2015 Jun; 5():10741. PubMed ID: 26038839
[TBL] [Abstract][Full Text] [Related]
28. Porphyromonas gingivalis attenuates the insulin-induced phosphorylation and translocation of forkhead box protein O1 in human hepatocytes.
Takamura H; Yoshida K; Okamura H; Fujiwara N; Ozaki K
Arch Oral Biol; 2016 Sep; 69():19-24. PubMed ID: 27214121
[TBL] [Abstract][Full Text] [Related]
29. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
30. Acetylated FoxO1 mediates high-glucose induced autophagy in H9c2 cardiomyoblasts: regulation by a polyphenol -(-)-epigallocatechin-3-gallate.
Liu J; Tang Y; Feng Z; Hou C; Wang H; Yan J; Liu J; Shen W; Zang W; Liu J; Long J
Metabolism; 2014 Oct; 63(10):1314-23. PubMed ID: 25062567
[TBL] [Abstract][Full Text] [Related]
31. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
32. The transcription factor COUP-TFII is negatively regulated by insulin and glucose via Foxo1- and ChREBP-controlled pathways.
Perilhou A; Tourrel-Cuzin C; Kharroubi I; Henique C; Fauveau V; Kitamura T; Magnan C; Postic C; Prip-Buus C; Vasseur-Cognet M
Mol Cell Biol; 2008 Nov; 28(21):6568-79. PubMed ID: 18765640
[TBL] [Abstract][Full Text] [Related]
33. Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.
Titchenell PM; Chu Q; Monks BR; Birnbaum MJ
Nat Commun; 2015 May; 6():7078. PubMed ID: 25963408
[TBL] [Abstract][Full Text] [Related]
34. A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism.
Cook JR; Matsumoto M; Banks AS; Kitamura T; Tsuchiya K; Accili D
Diabetes; 2015 Jun; 64(6):1951-65. PubMed ID: 25576059
[TBL] [Abstract][Full Text] [Related]
35. DMT efficiently inhibits hepatic gluconeogenesis by regulating the Gαq signaling pathway.
Zhou TT; Ma F; Shi XF; Xu X; Du T; Guo XD; Wang GH; Yu L; Rukachaisirikul V; Hu LH; Chen J; Shen X
J Mol Endocrinol; 2017 Aug; 59(2):151-169. PubMed ID: 28637808
[TBL] [Abstract][Full Text] [Related]
36. Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells.
Aw DK; Sinha RA; Xie SY; Yen PM
Biochem Biophys Res Commun; 2014 May; 447(4):569-73. PubMed ID: 24735537
[TBL] [Abstract][Full Text] [Related]
37. FoxO1 links hepatic insulin action to endoplasmic reticulum stress.
Kamagate A; Kim DH; Zhang T; Slusher S; Gramignoli R; Strom SC; Bertera S; Ringquist S; Dong HH
Endocrinology; 2010 Aug; 151(8):3521-35. PubMed ID: 20501674
[TBL] [Abstract][Full Text] [Related]
38. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1.
Fu Y; Chen A
Biochem Pharmacol; 2006 Jul; 72(2):227-38. PubMed ID: 16750517
[TBL] [Abstract][Full Text] [Related]
39. Epigallocatechin-3-gallate (EGCG) activates AMPK through the inhibition of glutamate dehydrogenase in muscle and pancreatic ß-cells: A potential beneficial effect in the pre-diabetic state?
Pournourmohammadi S; Grimaldi M; Stridh MH; Lavallard V; Waagepetersen HS; Wollheim CB; Maechler P
Int J Biochem Cell Biol; 2017 Jul; 88():220-225. PubMed ID: 28137482
[TBL] [Abstract][Full Text] [Related]
40. Hepatic Insulin Resistance Following Chronic Activation of the CREB Coactivator CRTC2.
Hogan MF; Ravnskjaer K; Matsumura S; Huising MO; Hull RL; Kahn SE; Montminy M
J Biol Chem; 2015 Oct; 290(43):25997-6006. PubMed ID: 26342077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]